352 related articles for article (PubMed ID: 17127391)
1. Myocardial extracellular matrix remodeling in ischemic heart failure.
Gallagher GL; Jackson CJ; Hunyor SN
Front Biosci; 2007 Jan; 12():1410-9. PubMed ID: 17127391
[TBL] [Abstract][Full Text] [Related]
2. MMP induction and inhibition in myocardial infarction.
Lindsey ML
Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
Lindsey ML; Iyer RP; Jung M; DeLeon-Pennell KY; Ma Y
J Mol Cell Cardiol; 2016 Feb; 91():134-40. PubMed ID: 26721597
[TBL] [Abstract][Full Text] [Related]
4. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
5. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
6. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
Spinale FG; Coker ML; Bond BR; Zellner JL
Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
[TBL] [Abstract][Full Text] [Related]
7. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
Vanhoutte D; Schellings M; Pinto Y; Heymans S
Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
[TBL] [Abstract][Full Text] [Related]
9. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
Spinale FG
Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.
DeLeon-Pennell KY; Meschiari CA; Jung M; Lindsey ML
Prog Mol Biol Transl Sci; 2017; 147():75-100. PubMed ID: 28413032
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix remodeling following myocardial injury.
Lindsey ML; Mann DL; Entman ML; Spinale FG
Ann Med; 2003; 35(5):316-26. PubMed ID: 12952018
[TBL] [Abstract][Full Text] [Related]
12. Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.
Lindsey ML; Zamilpa R
Cardiovasc Ther; 2012 Feb; 30(1):31-41. PubMed ID: 20645986
[TBL] [Abstract][Full Text] [Related]
13. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
14. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
Etoh T; Joffs C; Deschamps AM; Davis J; Dowdy K; Hendrick J; Baicu S; Mukherjee R; Manhaini M; Spinale FG
Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H987-94. PubMed ID: 11514263
[TBL] [Abstract][Full Text] [Related]
15. ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.
Podesser BK; Siwik DA; Eberli FR; Sam F; Ngoy S; Lambert J; Ngo K; Apstein CS; Colucci WS
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H984-91. PubMed ID: 11179039
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
Mani SK; Kern CB; Kimbrough D; Addy B; Kasiganesan H; Rivers WT; Patel RK; Chou JC; Spinale FG; Mukherjee R; Menick DR
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1391-401. PubMed ID: 25795711
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
[TBL] [Abstract][Full Text] [Related]
18. Myocardial infarct expansion and matrix metalloproteinase inhibition.
Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Baskin JM; Deschamps AM; Lowry AS; Escobar GP; Lucas DG; Yarbrough WM; Zile MR; Spinale FG
Circulation; 2003 Feb; 107(4):618-25. PubMed ID: 12566376
[TBL] [Abstract][Full Text] [Related]
19. Cardiac remodeling and failure From molecules to man (Part II).
Fedak PW; Verma S; Weisel RD; Li RK
Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
Li YY; Feldman AM
Drugs; 2001; 61(9):1239-52. PubMed ID: 11511020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
